The targeting construct modified exon 4 with the point mutation (c.272 T to C; ENSMUST00000041901) that results in the amino acid substitution of phenylalanine with serine. Flp-mediated recombination removed the FRT-flanked neomycin resistance cassette inserted into intron 4. (J:244562)